Potential Risks and Solutions Inconsistent Quality Risk: Peptides purchased from unverified vendors may contain contaminants or incorrect dosages
Based on data from the phase 2 clinical trial of retatrutide (NCT04881760), published in the New England Journal of Medicine in 2023, gastrointestinal adverse events were among the most frequently reported side effects across all dose groups
Ding, F., Wang, Q., Xie, C., Wang, M., Zhang, L., Gao, M., Yang, Z., Ma, J., Shi, X., Chen, W., Duan, S., Yuan, P., Li, Y., Ma, X., Wu, Y., Liu, J., Feng, X., Cheng, Q., Wang, Z., Li, X., Huang, J
Warnings And Precautions Do not use medication prescribed for another person
The "energy food" approach When appetite is suppressed and you can only eat small amounts, choosing the right foods becomes disproportionately important